Dachaigh › Luchd-obrach › Innovative Cellular Therapeutics, Inc.
Innovative Cellular Therapeutics, Inc.: Tuarastalan H-1B agus taic bhìosa
Chuir Innovative Cellular Therapeutics, Inc. 11 iarrtasan cumha-obrach a-steach airson bhìosaichean H-1B agus bhìosaichean co-cheangailte ann am bliadhnaichean ionmhais 2023–2026; le teisteanas: 11. Tuarastal meadhanach a chaidh a thabhann: $77,355.
A bheil Innovative Cellular Therapeutics, Inc. a’ toirt taic do bhìosaichean H-1B?
Chuir Innovative Cellular Therapeutics, Inc. 11 iarrtasan cumha-obrach a-steach ann am bliadhnaichean ionmhais 2023–2026, an tè as ùire air a chur a-steach air 7 Iuch 2025. Is e LCA a’ chiad cheum ann an iarrtas H-1B, mar sin tha an neach-fastaidh air taic a thoirt do luchd-obrach H-1B no air ullachadh airson sin a dhèanamh; cha gharantaich e taic airson dreuchd shònraichte sam bith. Thoir sùil air liostaichean obrach an neach-fastaidh fhèin.
Tuarastalan a rèir tiotal obrach
| Tiotal dreuchd | LCAs | Tuarastal meadhanach |
|---|---|---|
| Quality Control Manager | 3 | $79,997 |
| Cell Production Specialist | 2 | $68,151 |
| Production Supervisor | 1 | $69,285 |
| Manager of Clinical Testing | 1 | $72,862 |
| Senior Manager of Clinical Testing | 1 | $95,000 |
| Validation & Regulatory Affairs Engineer | 1 | $77,355 |
| Chief Scientific Officer | 1 | $142,000 |
| Associate Director | 1 | $80,000 |
Iarrtasan a rèir bliadhna ionmhais
| Bliadhna mhaoine | LCAs | Tuarastal meadhanach |
|---|---|---|
| FY2023 | 2 | $70,730 |
| FY2024 | 4 | $75,108 |
| FY2025 | 5 | $80,000 |
Ìrean tuarastail làithreach
Suidhichidh Roinn an Obrach ceithir ìrean tuarastail làithreach airson gach dreuchd agus sgìre, bho Ìre I (inntrigeadh) gu Ìre IV (gu tur comasach). Taghaidh an neach-fastaidh an ìre a fhreagras ri riatanasan na h-obrach.
Far a bheil na h-obraichean
Dreuchdan
- Molecular and Cellular Biologists4
- Bioengineers and Biomedical Engineers3
- Natural Sciences Managers2
- Industrial Engineers1
- Biochemists and Biophysicists1
Iarrtasan as ùire
| Tiotal dreuchd | Tuarastal bunasach | Àite | Air a chur a-steach | Ceann-latha tòiseachaidh | Inbhe |
|---|---|---|---|---|---|
| Associate Director | $80,000–$90,000 Ìre I | Rockville, MD | 7 Iuch 2025 | 1 Dàmh 2025 | Dearbhaichte |
| Quality Control Manager | $95,805–$105,000 Ìre II | Rockville, MD | 3 Ògmh 2025 | 1 Dàmh 2025 | Dearbhaichte |
| Chief Scientific Officer | $142,000–$152,000 Ìre II | Rockville, MD | 3 Ògmh 2025 | 1 Dàmh 2025 | Dearbhaichte |
| Quality Control Manager | $79,997 Ìre I | Rockville, MD | 25 Dàmh 2024 | 1 Faoi 2025 | Dearbhaichte |
| Cell Production Specialist | $63,440 Ìre I | Rockville, MD | 25 Dàmh 2024 | 1 Faoi 2025 | Dearbhaichte |
| Cell Production Specialist | $72,862–$82,862 Ìre I | Rockville, MD | 10 Ògmh 2024 | 1 Dàmh 2024 | Dearbhaichte |
| Manager of Clinical Testing | $72,862–$82,862 Ìre I | Rockville, MD | 10 Ògmh 2024 | 1 Dàmh 2024 | Dearbhaichte |
| Senior Manager of Clinical Testing | $95,000–$125,000 | Rockville, MD | 24 Cèit 2024 | 1 Dàmh 2024 | Dearbhaichte |
| Validation & Regulatory Affairs Engineer | $77,355–$80,000 Ìre I | Rockville, MD | 22 Cèit 2024 | 1 Dàmh 2024 | Dearbhaichte |
| Production Supervisor | $69,285 Ìre I | Rockville, MD | 11 Cèit 2023 | 1 Dàmh 2023 | Dearbhaichte |
| Quality Control Manager | $72,176–$78,000 Ìre I | Rockville, MD | 11 Cèit 2023 | 1 Dàmh 2023 | Dearbhaichte |
Is e na tuarastalan an ìre as ìsle den tuarastal a chaidh a thabhann air gach iarrtas, air an tionndadh gu suim bhliadhnail; cleachdaidh na staitistigean iarrtasan làn-aimsire le teisteanas a-mhàin. Chan eil LCA na aontachadh bhìosa agus faodaidh aon LCA còmhdach a dhèanamh air iomadh dreuchd. Stòr: Roinn an Obrach na SA, Dàta Foillseachaidh OFLC LCA, bliadhnaichean ionmhais 2023–2026 (co-dhùnadh as ùire 30 Ògmh 2026).